rethinkTHC Search
Menu
Study breakdown

Cannabis and Linden Tree Extracts Together Showed Powerful Neuroprotective Synergy

Animal StudyPreliminary evidence
The takeaway

Combining cannabis and Tilia (linden) extracts produced synergistic neuroprotection that fully restored cell viability against glutamate toxicity and shifted brain immune cells toward an anti-inflammatory state.

Botanical medicine researchers, neuroscience enthusiasts, and people interested in cannabis combination therapies.

Combined extracts: full neuroprotection vs partial alone

What the researchers found

Cannabis extract alone partially reversed glutamate-induced cell death (52-200% recovery). The linden tree extract also showed partial protection (22-82%). Combined, they produced synergistic effects: 133-284% recovery, fully restoring cell viability to control levels. The combination also reduced reactive oxygen species (52-58%) and most dramatically shifted microglia from inflammatory to anti-inflammatory phenotypes.

Why it matters

The synergistic effect means the combination works better than either extract alone, even at lower individual doses. This supports the concept of multi-botanical approaches for neuroinflammation and could inform formulation of botanical medicines.

The numbers in context

Cannabis alone: 52-200% viability recovery. Linden alone: 22-82%. Combined: 133-284% (full restoration). ROS reduction: 52-58%. Shifted microglia from pro-inflammatory phenotype 1 to anti-inflammatory phenotype 2.

How the study worked

In vitro study using HT-22 hippocampal neurons (glutamate toxicity model) and primary rat microglia (LPS inflammation model). Cell viability by MTT, ROS by fluorescence, microglial phenotypes by immunofluorescence.

What this study cannot tell us

In vitro cell culture only. The specific bioactive compounds responsible for the synergy are not identified. Extract composition varies by preparation method. Translation to in vivo brain effects is uncertain.

How to read the evidence

In vitro study only, demonstrating molecular synergy but far from clinical application.

When this study was published

2026 study.

The bigger picture

Both cannabis and linden have traditional uses for neurological conditions. Demonstrating molecular synergy between them provides scientific support for combination botanical therapies and the broader concept of phytomedicine.

Questions still open

  • Which specific compounds in each extract drive the synergy? Could this combination be effective in animal models of epilepsy or neurodegeneration?

Common questions

What is synergy in this context?
The combined effect of cannabis and linden extracts was greater than adding their individual effects together, producing full neuroprotection where each alone only provided partial protection.
Could this combination treat neurological conditions?
The cell culture results are promising but very preliminary. Animal and human studies would be needed to determine whether this synergy translates to actual neuroprotection in the brain.

Read the original research

Synergistic Neuroprotection by Cannabis sativa and Tilia × viridis: Attenuation of Hippocampal Neurons Glutamate-Induced Oxidative Stress and LPS-Driven Microglial Inflammation.

Planta medica

Citation

Saint Martin, Elina Malen; Barreiro-Arcos, María Laura; Gomez, María Belén; Soldavini, Giuliana Colonna; Marrassini, Carla; Cogoi, Laura; Peralta, Ignacio; Reinés, Analía; Alonso, María Rosario; Anesini, Claudia. (2026). Synergistic Neuroprotection by Cannabis sativa and Tilia × viridis: Attenuation of Hippocampal Neurons Glutamate-Induced Oxidative Stress and LPS-Driven Microglial Inflammation.. Planta medica. https://doi.org/10.1055/a-2751-0171

Explore the wider topic